{"id":"https://openalex.org/W1153890","doi":null,"title":"Open assessment of the safety and efficacy of thioridazine in the treatment of patients with borderline personality disorder.","display_name":"Open assessment of the safety and efficacy of thioridazine in the treatment of patients with borderline personality disorder.","publication_year":1989,"publication_date":"1989-01-01","ids":{"openalex":"https://openalex.org/W1153890","mag":"1153890","pmid":"https://pubmed.ncbi.nlm.nih.gov/2631134"},"language":"en","primary_location":{"id":"pmid:2631134","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2631134","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology bulletin","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028031641","display_name":"Martin H. Teicher","orcid":"https://orcid.org/0000-0002-6036-0177","observed_orcids":["https://orcid.org/0000-0002-6036-0177"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M H Teicher","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009792861","display_name":"Carol A. Glod","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C A Glod","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023670400","display_name":"S T Aaronson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S T Aaronson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004004163","display_name":"P A Gunter","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P A Gunter","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056450962","display_name":"Alan F. Schatzberg","orcid":"https://orcid.org/0000-0001-9421-8278","observed_orcids":["https://orcid.org/0000-0001-9421-8278"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A F Schatzberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5034220151","display_name":"Jonathan O Cole","orcid":"https://orcid.org/0000-0001-6302-7196","observed_orcids":["https://orcid.org/0000-0001-6302-7196"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J O Cole","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.5276,"has_fulltext":false,"cited_by_count":29,"citation_normalized_percentile":{"value":0.62921851,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"25","issue":"4","first_page":"535","last_page":"49"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11093","display_name":"Personality Disorders and Psychopathology","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11093","display_name":"Personality Disorders and Psychopathology","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/thioridazine","display_name":"thioridazine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/borderline-personality-disorder","display_name":"borderline personality disorder","score":0.9990000128746033},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.7879999876022339},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.7009999752044678},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.8240000009536743},{"id":"https://openalex.org/keywords/melancholic-depression","display_name":"endogenous depression","score":0.6499999761581421},{"id":"https://openalex.org/keywords/paranoid-ideation","display_name":"paranoid ideation","score":0.8130000233650208},{"id":"https://openalex.org/keywords/sedation","display_name":"sedation","score":0.6840000152587891},{"id":"https://openalex.org/keywords/erectile-dysfunction","display_name":"erectile dysfunction","score":0.8859999775886536},{"id":"https://openalex.org/keywords/weight-gain","display_name":"weight gain","score":0.6959999799728394},{"id":"https://openalex.org/keywords/interpersonal-relationships","display_name":"interpersonal relationships","score":0.42899999022483826},{"id":"https://openalex.org/keywords/impulsivity","display_name":"impulsivity","score":0.5059999823570251}],"concepts":[{"id":"https://openalex.org/C2780688371","wikidata":"https://www.wikidata.org/wiki/Q58375","display_name":"Thioridazine","level":3,"score":0.6010524034500122},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5942946672439575},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.569290816783905},{"id":"https://openalex.org/C2781214261","wikidata":"https://www.wikidata.org/wiki/Q2729863","display_name":"Hostility","level":2,"score":0.5447564721107483},{"id":"https://openalex.org/C2780600973","wikidata":"https://www.wikidata.org/wiki/Q2712836","display_name":"Borderline personality disorder","level":2,"score":0.5447528958320618},{"id":"https://openalex.org/C2778528637","wikidata":"https://www.wikidata.org/wiki/Q4967025","display_name":"Brief Psychiatric Rating Scale","level":3,"score":0.5409475564956665},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.489700585603714},{"id":"https://openalex.org/C70410870","wikidata":"https://www.wikidata.org/wiki/Q199906","display_name":"Clinical psychology","level":1,"score":0.4632253646850586},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.43913891911506653},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.39439570903778076},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3090780973434448},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20756351947784424},{"id":"https://openalex.org/C2778775820","wikidata":"https://www.wikidata.org/wiki/Q407972","display_name":"Chlorpromazine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001883","descriptor_name":"Borderline Personality Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001883","descriptor_name":"Borderline Personality Disorder","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013881","descriptor_name":"Thioridazine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013881","descriptor_name":"Thioridazine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:2631134","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2631134","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology bulletin","raw_type":"Journal Article"},{"id":"mag:1153890","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2631134","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2142653852","https://openalex.org/W2054099746","https://openalex.org/W2127606597","https://openalex.org/W1974395827","https://openalex.org/W3214094926","https://openalex.org/W4404505107","https://openalex.org/W2074930596","https://openalex.org/W1987859859","https://openalex.org/W2057131927","https://openalex.org/W7100119420"],"abstract_inverted_index":{"A":[0],"12-week":[1],"open":[2],"study":[3,108,147,171],"was":[4,66,123,203],"conducted":[5],"to":[6,30,84,101,190],"assess":[7,102],"the":[8,37,58,89,98,106,145,170,173],"possible":[9],"efficacy":[10],"and":[11,36,81,94,139,156,172,185,210,228],"safety":[12],"of":[13,60,97,175],"low-dose":[14],"thioridazine":[15,50,219],"in":[16,70,115,137,151],"11":[17],"outpatients":[18],"(8":[19],"women,":[20],"3":[21],"men)":[22],"with":[23,226],"borderline":[24],"personality":[25],"disorder":[26],"(BPD)":[27],"diagnosed":[28],"according":[29,189],"DSM-III-R":[31],"(American":[32],"Psychiatric":[33,72],"Association":[34],"1987)":[35,198],"Diagnostic":[38],"Interview":[39],"for":[40],"Borderline":[41],"Patients":[42],"(DIB;":[43],"Gunderson":[44],"et":[45,132,196],"al.":[46,133,197],"1981)":[47],"criteria.":[48],"Mean":[49],"dose":[51],"averaged":[52],"92":[53],"mg":[54],"per":[55],"day":[56],"across":[57],"duration":[59],"this":[61],"study.":[62],"At":[63],"endpoint,":[64],"there":[65],"a":[67,205],"significant":[68,121,149,206],"reduction":[69],"Brief":[71],"Rating":[73],"Scale":[74],"(BPRS;":[75],"Overall":[76],"&":[77],"Gorham":[78],"1988)":[79],"scores,":[80],"patients":[82,225],"appeared":[83],"be":[85],"less":[86],"symptomatic":[87],"on":[88,125,224],"impulse":[90],"action":[91],"patterns,":[92],"affects,":[93],"psychosis":[95],"subscales":[96],"DIB":[99],"(modified":[100],"change).":[103],"Subjects":[104,143],"completing":[105,144],"entire":[107,146],"(n":[109],"=":[110],"6)":[111],"also":[112],"showed":[113,148],"improvement":[114,122,150],"interpersonal":[116,154],"relations.":[117],"On":[118],"self-report":[119],"measures,":[120],"noted":[124],"most":[126],"Hopkins":[127],"Symptom":[128],"Checklist-90":[129],"(SCL-90;":[130],"Derogatis":[131],"1973)":[134],"subscales,":[135],"particularly":[136],"hostility":[138],"additional":[140],"depressive":[141],"features.":[142],"paranoid":[152,186],"ideation,":[153],"sensitivity,":[155],"anxiety.":[157],"Three":[158],"patients,":[159],"however,":[160],"developed":[161],"sustained":[162],"melancholic":[163],"depressions":[164],"that":[165,218,229],"necessitated":[166],"their":[167],"discontinuation":[168],"from":[169],"initiation":[174],"anti-depressant":[176],"treatment.":[177],"These":[178],"three":[179],"individuals":[180],"were":[181],"more":[182],"schizotypal,":[183],"schizoid,":[184],"at":[187],"baseline":[188],"Personality":[191],"Disorder":[192],"Examination":[193],"(PDE;":[194],"Loranger":[195],"structured":[199],"interviews.":[200],"Weight":[201],"gain":[202],"not":[204],"problem,":[207],"but":[208],"sedation":[209],"erectile":[211],"dysfunction":[212],"were.":[213],"Overall,":[214],"these":[215],"findings":[216],"suggest":[217],"may":[220],"exert":[221],"prominent":[222],"effects":[223],"BPD":[227],"double-blind,":[230],"placebo-controlled":[231],"studies":[232],"are":[233],"warranted.":[234]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}